-
JOH丨Optimizing Algorithms to Narrow the Gray Zone in Diagnosing Clinically Significant Portal Hypertension
Non-invasive tests (NITs), such as liver stiffness measurement (LSM), spleen stiffness measurement (SSM), and platelet count (PLT), have been validated for diagnosing CSPH and predicting decompensation risk. However, these methods…
-
Dr. Hongzhou Lu: Driving High-Quality Development in Infectious Disease Prevention with Innovative Productivity at the 15th Tuberculosis Oriental Forum
1. Understanding New Quality Productivity in Medicine: Key Scientific and Technological Innovations in Infectious Disease Prevention Professor Lu explains, “Across human history, breakthrough developments in every field have been driven…
-
ESMO 2024丨Dr. Junyuan Qi: Cutting Through the Fog, Promising Phase I Results for the New BCL-2 Inhibitor in R/R NHL and AML
From September 13th to 17th, the 2024 European Society for Medical Oncology (ESMO) Annual Meeting was held in Barcelona, Spain. As one of the world’s top oncology conferences, it brought together experts and scholars from across the globe to share cutting-edge research findings and discuss future directions. At the session dedicated to hematologic malignancies, Dr.…
-
Dr. Yao Zhu: Tailoring Prostate Cancer Treatment in China, Fudan University Shanghai Cancer Center’s Team Explores Strategies to Benefit More Patients
Due to factors such as early screening, drug accessibility, and genetic differences, prostate cancer characteristics in China differ from those in Western countries. In recent years, with China’s aging population, the incidence and mortality of prostate cancer have risen significantly, increasing the disease burden. At the recent CSCO Annual Meeting, Urology Frontier invited Dr. Yao…
-
CUA 2024丨Dr. Jian Huang Shares Key Areas of Focus at the CUA Annual Meeting and Sun Yat-sen Memorial Hospital ’s Bladder Cancer Research
The 31st Urology Academic Conference, organized by the Chinese Medical Association and the Chinese Urological Association (CUA), was held from September 19 to 22, 2024, at the National Convention Center in Tianjin. This event brought together leading urology experts from China and abroad to discuss the latest advances in clinical research and surgical treatment. After…
-
Dr. Qiang Wei: Precision Endocrine Therapy for Prostate Cancer Enters a New Era as the West China Hospital Continues to Pioneer Diagnostic
Prostate cancer is one of the most common malignancies in men, with endocrine therapy being a standard treatment approach. However, it often comes with some side effects. Recently, the 31st Annual Urology Conference, hosted by the Chinese Medical Association and the Chinese Urological Association (CUA), was held from September 19-22, 2024, at the Tianjin National…
Connecting Medical Expertise through Media
